1-7 of 7
Anthony J. Perissinotti
Close
Sort by
Journal Articles

Multicenter Retrospective Evaluation of Treatment of High-Risk Acute Promyelocytic Leukemia (APL): Results from the Hematology Research Outcomes (HERO) Consortium

Lydia Benitez, Kayleigh R. Marx, Kaitlyn M. Buhlinger, Stephen M. Clark, Justin H. Reid, Caitlin R Rausch, Katie S Gatwood, Sarah E. Stump, Richa Shah, Jenna Ciervo, Jeffrey Baron, Bernard Lawrence Marini, Anthony J. Perissinotti, Madeline Waldron, Benyam Muluneh
Journal: Blood
Blood (2023) 142 (Supplement 1): 4267.
https://doi.org/10.1182/blood-2023-189637
Published: 2023
Journal Articles

Real-World Outcomes with Immunosuppressive Therapy for Aplastic Anemia in Patients Treated at the University of Michigan

Daniel H. Foley, Charles E. Foucar, Kristen M. Pettit, Patrick W. Burke, Lydia L. Benitez, Anthony J. Perissinotti, Bernard L. Marini, Dale L. Bixby
Journal: Blood
Blood (2021) 138 (Supplement 1): 1126.
https://doi.org/10.1182/blood-2021-146454
Published: 2021
Journal Articles

Efficacy of HMA +/- Venetoclax or Intensive Chemotherapy in Blast-Phase Myeloproliferative Neoplasms

James J. Yoon, Lydia L. Benitez, Dale L. Bixby, Patrick W. Burke, Bernard L. Marini, Anthony J. Perissinotti, Moshe Talpaz, Kristen M. Pettit
Journal: Blood
Blood (2021) 138 (Supplement 1): 2569.
https://doi.org/10.1182/blood-2021-151352
Published: 2021
Journal Articles

Risk of Opportunistic Infections in Patients with Bendamustine-Associated Lymphopenia and the Utility of Antimicrobial Prophylaxis

Jayasree Krishnan, MD, Victoria Nachar, PharmD, Bernard Lawrence Marini, PharmD, Anthony J. Perissinotti, PharmD, Tycel J. Phillips, MD, Mark S Kaminski, MD, Shannon A. Carty, MD, Ryan A. Wilcox, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 50.
https://doi.org/10.1182/blood-2020-142763
Published: 2020
Journal Articles

Multi-Center Retrospective Evaluation of High-Dose Cytarabine Based Induction Versus CPX-351 Induction in Patients with Secondary AML

Lydia Benitez, PharmD, Anthony J. Perissinotti, PharmD, Caitlin R. Rausch, PharmD, Jeff Klaus, PharmD, Stephen Michael Clark, PharmD, Michael Filtz, PharmD, Kelley L Ratermann, PharmD, Carissa F. Treptow, PharmD, Shawn Griffin, PharmD, Marissa Olson, PharmD, Mallory Crain, PharmD, Kristen Pettit, MD, Patrick W. Burke, MD, Dale L. Bixby, MD, Bernard Lawrence Marini, PharmD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2639.
https://doi.org/10.1182/blood-2019-122189
Published: 2019
Journal Articles

Lenalidomide Plus Hypomethylating Agent for Acute Myeloid Leukemia (AML) with Recurrent Genetic Abnormalities -AML with Inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, Mecom

Lauren E. Merz, BA, Anthony J. Perissinotti, PharmD, Bernard Lawrence Marini, PharmD, Ashley Crouch, BS, Kristen Pettit, MD, Patrick W. Burke, MD, Harry P. Erba, MD PhD, Dale L. Bixby, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4042.
https://doi.org/10.1182/blood-2018-99-110854
Published: 2018
Journal Articles

Therapeutic Outcomes of Patients with Acute Erythroid Leukemia Treated with Hypomethylating Agents

Richard King, MD, Ashley Crouch, B.S., Vedran Radojcic, MD, Bernard Lawrence Marini, PharmD, Anthony J. Perissinotti, PharmD, Dale L. Bixby, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5203.
https://doi.org/10.1182/blood.V128.22.5203.5203
Published: 2016